DrugBaron
JANUARY 31, 2024
No surrogate marker (selecting a development candidate, starting human trials, or (arguably) even launching a drug are reliable indicators of the only things that matter: real-world clinical utility and commercial success.
BenchSci
MARCH 6, 2024
This surge has demonstrated to budget holders and decision-makers alike the significant impact AI can have when effectively applied, offering immense potential to accelerate drug discovery and development across various stages, from unraveling the complexity of disease biology to refining drug design and expediting clinical trials.
Expert insights. Personalized for you.
165 
Let's personalize your content